Fecal Microbiota Transplant for Patients With Chronic Pouchitis

Status Not yet recruiting

Clinical Trial Summary

The purpose of this research study is to assess the safety and efficacy of fecal microbiota transplant (FMT) in the treatment of chronic pouchitis.

Clinical Trial Description

The purpose of this research study is to assess the safety and efficacy of fecal microbiota transplant (FMT) in the treatment of chronic pouchitis. FMT has been successfully used in the treatment of recurrent Clostridiodes difficile infection and has shown benefit in the treatment of ulcerative colitis in clinical trials. The success of FMT in these patients is because of the reconstitution of the recipient's unhealthy gut bacteria with the donor's healthy gut bacteria. Surgery to remove the colon is required in a subset of patients with ulcerative colitis that does not respond to medical therapy. In these patients, an internal pouch is created from small intestine to function as a stool reservoir and avoid an ostomy after the colon is removed. Inflammation of the pouch, pouchitis, is common after surgery and can manifest as diarrhea, pelvic pain, urgency and blood in the stool. Chronic pouchitis occurs in up to 20% of patients and there is no approved treatment. A number of studies have evaluated FMT in patients with chronic pouchitis, but have proven unsuccessful. This is likely because these studies have used stool from patients with a colon and transplanted it into patients with a pouch. This is problematic because the gut bacteria of the colon and pouch are not similar, and putting healthy stool from a colon may not reconstitute a healthy pouch microbiome. The specific purpose of this project is to transplant stool from patients with a healthy pouch to patients with an inflamed pouch. ;

Study Design

Related Conditions & MeSH terms

Pouchitis

Clinical Trial Details

NCT number	NCT05829109
Study type	Interventional
Source	Icahn School of Medicine at Mount Sinai
Contact	Maia Kayal, MD, MS
Phone	212-241-0150
Email	Maia.Kayal@mountsinai.org
Status	Not yet recruiting
Phase	Early Phase 1
Start date	September 2024
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04979832` - GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery	Phase 1/Phase 2
Terminated	`NCT00061282` - Clotrimazole Enemas for Pouchitis in Children and Adults	Phase 1/Phase 2
Recruiting	`NCT03136419` - Microbiota and Immune microEnvironment in Pouchitis	N/A
Withdrawn	`NCT04640155` - Treating Chronic Pouchitis With a Low FODMAP Diet	N/A
Completed	`NCT02201186` - To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis	Phase 2
Completed	`NCT02790138` - A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis	Phase 4
Not yet recruiting	`NCT01202396` - The Interaction Between Intestinal Microbiota, Innate Defense and Epithelial Integrity in the Development of Pouchitis	N/A
Completed	`NCT02428361` - Fecal Microbiota Transplant (FMT) for Pouchitis	Early Phase 1
Completed	`NCT03538366` - Fecal Microbiota Transplantation for Chronic Pouchitis	N/A
Completed	`NCT04763564` - Efficacy of Liraglutide Therapy in Patients With IPAA	Phase 2
Terminated	`NCT00583531` - Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis	Phase 2
Recruiting	`NCT03524352` - the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis	Phase 3
Completed	`NCT04820413` - Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis	N/A
Not yet recruiting	`NCT06443502` - A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis	Phase 3
Recruiting	`NCT04089345` - Stelara fOr ChRonic AntibioTic rEfractory pouchitiS	Phase 3
Not yet recruiting	`NCT03526796` - Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis	N/A
Terminated	`NCT02782325` - Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)	Phase 1/Phase 2
Completed	`NCT02828410` - Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA	N/A
Recruiting	`NCT05578313` - Inflammatory Bowel Diseases (IBD) Cannabis Registry
Not yet recruiting	`NCT06316999` - Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis	N/A